- Home
- EHI vs AMRN Comparison
EHI vs AMRN Comparison
Compare EHI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHI
- AMRN
- Stock Information
- Founded
- EHI 2003
- AMRN 1989
- Country
- EHI United States
- AMRN Ireland
- Employees
- EHI N/A
- AMRN N/A
- Industry
- EHI Investment Managers
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EHI Finance
- AMRN Health Care
- Exchange
- EHI Nasdaq
- AMRN Nasdaq
- Market Cap
- EHI 194.8M
- AMRN 216.0M
- IPO Year
- EHI N/A
- AMRN 1993
- Fundamental
- Price
- EHI $6.43
- AMRN $11.95
- Analyst Decision
- EHI
- AMRN Sell
- Analyst Count
- EHI 0
- AMRN 2
- Target Price
- EHI N/A
- AMRN $7.00
- AVG Volume (30 Days)
- EHI 44.5K
- AMRN 75.5K
- Earning Date
- EHI 01-01-0001
- AMRN 05-07-2025
- Dividend Yield
- EHI 11.54%
- AMRN N/A
- EPS Growth
- EHI N/A
- AMRN N/A
- EPS
- EHI N/A
- AMRN N/A
- Revenue
- EHI N/A
- AMRN $214,112,000.00
- Revenue This Year
- EHI N/A
- AMRN N/A
- Revenue Next Year
- EHI N/A
- AMRN $5.97
- P/E Ratio
- EHI N/A
- AMRN N/A
- Revenue Growth
- EHI N/A
- AMRN N/A
- 52 Week Low
- EHI $6.00
- AMRN $7.08
- 52 Week High
- EHI $7.75
- AMRN $17.58
- Technical
- Relative Strength Index (RSI)
- EHI 53.23
- AMRN 69.15
- Support Level
- EHI $6.26
- AMRN $11.27
- Resistance Level
- EHI $6.42
- AMRN $11.84
- Average True Range (ATR)
- EHI 0.05
- AMRN 0.50
- MACD
- EHI 0.01
- AMRN 0.08
- Stochastic Oscillator
- EHI 89.47
- AMRN 83.83
About EHI Western Asset Global High Income Fund Inc
Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income and total return by investing in a world-wide portfolio of securities. The fund invests in various sectors such as Consumer Discretionary, Energy, Healthcare, Industrials, materials, and others.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.